APA (7th ed.) Citation

Li Gu, Xin Jin, Huaiyuan Liang, Chong Yang, & Yu Zhang. (2023). Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complex. Elsevier.

Chicago Style (17th ed.) Citation

Li Gu, Xin Jin, Huaiyuan Liang, Chong Yang, and Yu Zhang. Upregulation of CSNK1A1 Induced by ITGB5 Confers to Hepatocellular Carcinoma Resistance to Sorafenib in Vivo by Disrupting the EPS15/EGFR Complex. Elsevier, 2023.

MLA (9th ed.) Citation

Li Gu, et al. Upregulation of CSNK1A1 Induced by ITGB5 Confers to Hepatocellular Carcinoma Resistance to Sorafenib in Vivo by Disrupting the EPS15/EGFR Complex. Elsevier, 2023.